Search

Your search keyword '"Central nervous system depressants -- Research"' showing total 5 results
Start Over Descriptor "Central nervous system depressants -- Research" Publisher right vision media
5 results on '"Central nervous system depressants -- Research"'

1. New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model

Subjects
Purdue Pharma L.P. -- Reports, Central nervous system depressants -- Research, Fentanyl -- Research, Naloxone -- Research, General interest, News, opinion and commentary
Abstract

STAMFORD: PURDUE PHARMA L.P has issued the following news release: Purdue Pharma L.P. ('Purdue') today announced The Journal of Clinical Pharmacology has published findings from a study in healthy adult [...]

Published
2024

2. Findings Presented at PAINWeek 2024 Demonstrate Tris Pharma's Investigational, First-in-Class Therapy Cebranopadol Provides Potent, Prolonged Pain Relief with Improved Safety Over Oxycodone

Subjects
Research, Safety and security measures, Attention deficit hyperactivity disorder -- Research, Central nervous system depressants -- Research, Oxycodone -- Research, Nervous system diseases -- Research, Pain management -- Research -- Safety and security measures, Attention-deficit hyperactivity disorder -- Research, Pain -- Care and treatment
Abstract

MONMOUTH JUNCTION: Tris Pharma, Inc. has issued the following news release: Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological [...]

Published
2024

3. New Research Finds Telehealth to be a Safe and Effective Option For Those Undergoing Addiction Treatment in the Fentanyl Era

Subjects
Central nervous system depressants -- Research, Addiction -- Research -- Care and treatment, Buprenorphine -- Research, Fentanyl -- Research, Evidence-based medicine -- Research, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

NEW YORK: Ophelia has issued the following news release: Ophelia Health, an Opioid Use Disorder (OUD) care provider, today shared findings from its poster presentation at the Annual ASAM Conference, [...]

Published
2023

4. Study Finds Video DOT Could Increase Access to Methadone Treatment and Reduce Risk

Subjects
Patient compliance -- Reports -- Research, Central nervous system depressants -- Research, Behavioral health care -- Research -- Reports, Substance abuse -- Care and treatment, Methadone hydrochloride -- Research, General interest, News, opinion and commentary
Abstract

BALTIMORE: emocha Health has issued the following news release: For those striving to manage opioid use disorder, daily, in-person dosing (Directly Observed Therapy, or DOT) is the standard of care. [...]

Published
2022

5. Epic Research: Only 5% of Overdose Patients Tested for Fentanyl, #1 Killer of Americans 18-45

Subjects
Drugs -- Overdose, Central nervous system depressants -- Research, Fentanyl -- Research, General interest, News, opinion and commentary
Abstract

VERONA: Epic Research has issued the following news release: Overdoses--often from substances laced with fentanyl-- and other unintentional injuries are now the top cause of death for Americans aged 1 [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results